BioScrip Can't Hide Behind Omnicare In Securities Suit
By Cara Salvatore ( June 8, 2015, 10:25 PM EDT) -- A New York federal judge on Friday found that the U.S. Supreme Court's recent Omnicare ruling doesn't shut down a claim that BioScrip Inc. says was wrongly left over in a securities class action alleging it made misleading statements about its compliance with the False Claims Act and covered up an investigation into a large kickback scheme....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.